Jerome Pesenti, CEO at BenevolentTech will be joining Data Driven Event held at Bloomberg LP to discuss how BenevolentAI artificial intelligence can accelerate drug discovery
Join Ken Mulvany and James Chandler at the CEC Capital Summit
Join a select group of 250 practitioners, researchers, entrepreneurs and investors to explore current and future industry applications of groundbreaking new technologies in healthcare.
Solving the world’s most pressing challenges through open innovation and partnership.
Meet Ken Mulvany at Rutberg Summit presenting BenevolentAI's work on Artificial Intelligence applied to drug discovery
with Professor Jackie Hunter, CEO at Stratified Medical, a BenevolentAI company